FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 3211156 · Received July 8, 2013

Report

Report Number
2124215-2013-08029
Event Type
Injury
Date Received
July 8, 2013
Date of Event
May 2, 2013
Report Date
May 2, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT ATRIAL LEAD HAD INCREASE OUT OF RANGE PACING IMPEDANCES AND INCREASE PACING THRESHOLDS. A NEW RIGHT ATRIAL LEAD WAS IMPLANTED. THIS RIGHT ATRIAL LEAD WAS SURGICALLY ABANDONED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310368 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4096

Patients

Seq Age Sex Outcome Treatment
1 70 YR Hospitalization| L| R 0175| P143| 4096| 0185| 5076| H230| 4542| 4543| 0181